Navigation Links
Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
Date:5/9/2011

he information is not necessarily comparable to other companies and should be considered as a supplement to, not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP.

Contact Information:
Laurie W. Little
949-461-6002
laurie.little@valeant.com

Financial Tables follow.Valeant Pharmaceuticals International, Inc. Table 1 Condensed Consolidated Statement of Income (Loss)For the Three Months Ended March 31, 2011 and 2010Three Months EndedMarch 31,(In thousands, except per share data)

20112010% ChangeProduct sales

$ 500,421$ 212,033NMAlliance and royalty

58,4144,349NMService and other

6,1913,253NMTotal revenues

565,026219,635NMCost of goods sold

169,28758,955NMCost of services

3,2103,307NMCost of alliances

30,735-NMSelling, general and administrative ("SG&A")

139,50643,513NMResearch and development

13,67012,577NMAcquired in-process research and development

2,00051,003NMLegal settlements

400-NMRestructuring and acquisition-related costs

19,046613NMAmortization of intangible assets

112,04333,300NM489,897203,268Operating income

75,12916,367Interest expense, net

(68,334)(9,639)Loss on extinguishment of debt

(8,262)-Gain (loss) on investments, net

1,769(155)Other income (expense), net including translation and exchange

2,807(623)Income before (recovery of) provision for income taxes

3,1095,950(Recovery of) provision for income taxes

(3,373)9,100Net income (loss)

$
,482
$   (3,150)Earnings per share:Basic:Net income (loss)

$
.02

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Valeant to Acquire Polish Products
2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
8. Valeant Announces Pricing of Senior Notes
9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... JOLLA, Calif. , June 1, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that Kleanthis G. Xanthopoulos , Ph.D. has ... as a member of Regulus, Board of Directors, ... biotechnology industry.  Paul Grint, M.D., who previously served ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
(Date:6/1/2015)... June 1, 2015 Select Medical Holdings Corporation ... Corporation, a joint venture that Select Medical Corporation ("Select") ... completed its previously announced acquisition of Concentra Inc.  Cressey ... venture. About Select Medical Corporation ... hospitals and outpatient rehabilitation clinics in the ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Dec. 22, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ... 910801.TW), China,s leading integrated healthcare enterprise, today announced that ... market, accumulating a total of 36,976,000 shares in December ... shares at a weighted average price of HK$0.83 per ...
... question confronting neuroscientists and computer vision researchers alike is how ...  Introspectively, we know that the human brain solves this problem ... know what it is. But teaching a computer ... research published this fall in the Public Library of ...
Cached Medicine Technology:Golden Meditech Further Repurchases Shares 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 3Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 4
(Date:6/2/2015)... June 02, 2015 Specialty Technical ... compliance and risk solutions , and Radar today ... management effectiveness gap-improvement program. , All organizations need ... on objectives. Organizations not only assess and treat ... to do this (risk managing) thereby embedding these ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Lynn Lester as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... honor Lynn Lester with this prestigious award,” said NAPW ...
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in safety, environment, health ... organization exclusively for professional women, boasting more than 700,000 ... pleased to present Lourinda with this important honor,” said ...
(Date:6/1/2015)... June 02, 2015 The National ... Tansey as a 2015-2016 inductee into its VIP ... this prestigious distinction for leadership in mental health. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor," said NAPW President Star Jones. ...
(Date:6/1/2015)... 2015 Carson Energy also announced they ... IRA transactions. AdvantaIRA Trust, LLC is the country’s largest ... to fund positions using IRA’s does 2 things:, 1. ... project, even if there current cash position will not ... source for Carson and their investors to be able ...
Breaking Medicine News(10 mins):Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4Health News:National Association of Professional Women Inducts Lynn Lester, Director of Clinical Operations/CEO, Recovery Treatment Center, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:NAPW Inducts Selma Tansey, Executive Director of Washington Communities Human Services, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2
... five elderly Americans living on their own takes a ... and illness. According to the report, more than 21% ... least one of these 33 potentially inappropriate medications in ... people should always avoid, including certain sedatives, long-acting drugs ...
... amounts of heart tissue is as safe for babies as ... radiofrequency catheter ablation (RFCA) treatment involves threading a catheter - ... of the heart which is struggling with an uncontrolled heartbeat, ... radiofrequency energy, similar to microwave heat, is used to destroy ...
... everything from heartburn to impotence have prompted one in eight ... retain critical information about the drug and possible side effects. ... Food and Drug Administration set up rules and made them ... have a considerable effect -- nearly a third of adults ...
... Group therapy can help breast cancer patients feel better, but ... therapy in addition to their medical treatment lived an average// ... therapy did not live any longer than the 77 who ... did report less pain and emotional distress -- especially if ...
... pump up their physiques should know that many over-the-counter ... Many people who buy these supplements are getting ripped ... that they purchased in stores. They analyzed the products ... listed on the label were actually contained in the ...
... and Drugs Department is beginning to bare its fangs ... offence under the Indian Drugs and Cosmetics Act, 1940. ... this common practice jeopardise the health of the masses ... drugs -- it also endangers the job prospects of ...
Cached Medicine News:
... into the punctal opening to block tear ... long-term relief of dry eye symptoms, and ... its own natural tears:, Low-profile cap ... of cap design facilitates easy removal with ...
Extended Duration absorbable plugs are designed to provide patient comfort for up to 3 months. This long lasting plug is effective and economical for transient dry eye symptoms following surgery. Ext...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Attain™ Left-heart Lead Options to Fit Your Patient's Anatomy. Navigate moderately to greatly angled veins with high tortuosity....
Medicine Products: